Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study.
暂无分享,去创建一个
Gerald Beck | Steve Schwab | William Clark | Tom Greene | John K Leypoldt | Nathan W Levin | G. Beck | G. Eknoyan | M. Rocco | A. Cheung | A. Levey | T. Greene | L. Agodoa | W. Clark | J. Leypoldt | N. Levin | D. Ornt | S. Schwab | Andrew S Levey | G. Schulman | Alfred K Cheung | Garabed Eknoyan | Lawrence Agodoa | Gerald Schulman | Michael V Rocco | Daniel B Ornt | B. Teehan | J. Bailey | James Bailey | Brendan Teehan
[1] B. Descamps-Latscha,et al. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] H. Müller,et al. Levels of alpha1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. , 2001, Kidney international.
[3] C. Tetta,et al. Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis. , 2001, Artificial organs.
[4] S. Nishi,et al. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. , 1997, Kidney international.
[5] A. Kaplan,et al. Dialysate protein losses with bleach processed polysulphone dialyzers. , 1995, Kidney international.
[6] H. F. Woods,et al. Nephrology Dialysis Transplantation Improved Outcome for Haemodialysis Patients Treated with High-flux Membranes , 2022 .
[7] B. Pereira,et al. Hematocrit Level Associated Mortality in Hemodialysis Patients, by Ma JZ, Ebben J, Xia H, Collins AJ. J Am Soc Nephrol 10:610–619, 1999 , 2000, Seminars in dialysis.
[8] Johanna T Dwyer,et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2002, The New England journal of medicine.
[9] M. Schambelan,et al. Leptin, body composition, and indices of malnutrition in patients on dialysis. , 1998, Journal of the American Society of Nephrology : JASN.
[10] A. Cheung,et al. Single Compartment Models for Evaluating β2-Microglobulin Clearance During Hemodialysis , 1997, ASAIO journal.
[11] B. Maldague,et al. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. , 1991, Kidney international.
[12] W. Hörl,et al. Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. , 1995, Journal of the American Society of Nephrology : JASN.
[13] B. Jaber,et al. Effect of formaldehyde/bleach reprocessing on in vivo performances of high-efficiency cellulose and high-flux polysulfone dialyzers. , 1998, Journal of the American Society of Nephrology : JASN.
[14] N. Levin,et al. Improvement of plasma lipoprotein profiles during high-flux dialysis. , 1993, Journal of the American Society of Nephrology : JASN.
[15] L. Agodoa,et al. United States Renal Data System (USRDS). , 2000, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[16] R. Tibshirani,et al. Monographs on statistics and applied probability , 1990 .
[17] D. Marcelli,et al. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. , 1999, Kidney international.
[18] R. Lindsay,et al. A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. , 1989, American Journal of Kidney Diseases.
[19] J. Kusek,et al. Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. , 2001, Kidney international.
[20] J. Uribarri,et al. Middle molecule clearance does not influence protein intake in hemodialysis patients. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] R. Wolfe,et al. Relationship of dialysis membrane and cause-specific mortality. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] J. Hornberger,et al. A multivariate analysis of mortality and hospital admissions with high-flux dialysis. , 1992, Journal of the American Society of Nephrology : JASN.
[23] R. Wolfe,et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] J. Bergstrom. Mechanisms of uremic suppression of appetite. , 1999, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[25] A. Cheung,et al. Effects of Hemodialyzer Reuse on Clearances of Urea and β2-Microglobulin , 1999 .
[26] P. Södersten,et al. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. , 1996, Journal of the American Society of Nephrology : JASN.
[27] E G Lowrie,et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. , 1993, The New England journal of medicine.
[28] W. Hörl,et al. Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[29] T. Greene,et al. Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: effects of age, race, and gender. , 2003, Kidney international.
[30] John T Daugirdas,et al. Dialyzer Performance in the HEMO Study:In Vivo K0A and True Blood Flow Determined from a Model of Cross-Dialyzer Urea Extraction , 2004, ASAIO journal.
[31] R. Vanholder,et al. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. , 1991, Kidney international.
[32] George A Kaysen,et al. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. , 2002, Kidney international.
[33] T A Ikizler,et al. Amino acid and albumin losses during hemodialysis. , 1994, Kidney international.
[34] D.,et al. Regression Models and Life-Tables , 2022 .
[35] R. Marcén,et al. Effect of different membranes on amino-acid losses during haemodialysis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.